Editor's Note
The Food and Drug Administration (FDA) on September 22 amended the emergency use authorization (EUA) for Pfizer-BioNTech’s COVID-19 vaccine to allow for use of a single booster to be administered at least 6 months after completion of the primary series in those:
The authorization applies only to the Pfizer-BioNTech vaccine.
Read More >>Robotic surgery has moved from cutting-edge to commonplace. The question…
Office-based surgery (OBS) is one of the fastest-growing care settings…
Stress and burnout are more than workforce concerns; they are…